Beiyu Liu

Beiyu Liu

Auto-generated profile, based on publicly available information

Beiyu Liu

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2022 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
SJSimon W. Jiang
Simon W. Jiang
JKJeffery T. Kwock
Jeffery T. Kwock
BLBeiyu Liu
Beiyu Liu
APAmy Petty
Amy Petty
AZAaron T. Zhao
Aaron T. Zhao
TJTarannum Jaleel
Tarannum Jaleel

8 February 2023 in Dermatology and Therapy
Verified
Journal Article
Open access
PDF file
APAkash D. Patel
Akash D. Patel
CRChandler W. Rundle
Chandler W. Rundle
BLBeiyu Liu
Beiyu Liu
CGCynthia L. Green
Cynthia L. Green
CBChristian L. Bailey-Burke
Christian L. Bailey-Burke
MKMeenal Kheterpal
Meenal Kheterpal
Introduction Limited data exist regarding demographic-specific teledermatology (TD) utilization during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine TD utilization trends during the pandemic. Methods A retrospective cohort study for national and institutional populations was conducted. Patient encounters in the American Academy of Dermatology’s DataDerm registry (DataDerm) were analyzed from 1 April 2020 through 30 June 2021. All dermatological patients seen by Duke University Health Systems (DUHS) were analyzed from 1 March 2020 through 30 April 2021. In-person clinic visits versus TD encounters (national and institutional) and no-show rates (institutional only) were collected for visit type (i.e., TD versus in-person), sex, race, age/generation, and in- versus out-of-state location (national only). TD utilization is defined as the cohort of interest using TD (e.g., females, whites) within a demographic group (i.e., sex, race) as a percentage of total TD users. This was compared with in-person utilization during the identical timeframe. Results For US national data, 13,964,816 encounters were analyzed. Sex, race, age, and location each had a significant association with TD utilization (adjusted p < 0.001). For institutional data, 54,400 encounters were analyzed. Sex, race, and age had a significant association with TD utilization (adjusted p < 0.001). Both datasets revealed majority female populations for telehealth visits (DataDerm 66.0%; DUHS 61.7%). Non-white populations accounted for a higher percentage of TD utilizers (DataDerm 15.0%; DUHS 37.3%) when compared with in-person utilizers (DataDerm 11.7%; DUHS 22.3%). Younger patients utilized TD (DataDerm 63.6%; DUHS 62.6%) more than in-person services (DataDerm 26.3%; DUHS 43.8%). Institutional no-show rates between telehealth and in-person visits were lower for Black patients (11.8% versus 19.2%), other non-white races (10.6% versus 13.6%), and younger ages/generations (9.8% versus 12.8%), respectively. TD utilization decreased over time nationally as a percentage of total visits (2.9% versus 0.3%) in 2020 versus 2021, respectively. Conclusions and Relevance During the COVID-19 pandemic, certain populations (females, younger patients, non-white races) showed higher TD utilization. Understanding TD utilization trends is critical in defining the role of virtual care for improving universal care access, optimizing resources, and informing future healthcare models for all patient populations.

31 January 2022 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
NWNakiya Whitfield
Nakiya Whitfield
PGPatrick Gregory
Patrick Gregory
BLBeiyu Liu
Beiyu Liu
SSSusan Spratt
Susan Spratt
BSBenjamin H. Smith
Benjamin H. Smith

26 November 2022 in JID Innovations
Verified
Journal Article
Open access
MFM. Seth Flynn
M. Seth Flynn
CRCamille Robinson
Camille Robinson
SPSurya Patel
Surya Patel
BLBeiyu Liu
Beiyu Liu
CGCynthia L. Green
Cynthia L. Green
MPMichelle Pavlis
Michelle Pavlis
Patients with Parkinson disease (PD) are at high risk for developing melanoma, although current literature lacks details on the associated clinicopathologic characteristics. Our retrospective case-control study aimed to guide skin cancer surveillance recommendations for patients with PD, focusing on tumor sites. Our study included 70 adults with concurrent diagnoses of PD and melanoma from January 1, 2007 to January 1, 2020 at Duke University and 102 age-, sex-, and race-matched controls. The head/neck region accounted for 39.5% of invasive melanomas in the case group compared with 25.3% in the control group as well as 48.7% of noninvasive melanomas in the case group compared with 39.1% in the control group. Of note, 50% of metastatic melanomas in patients with PD originated on the head and neck (n = 3). Logistic regression showed 2.09 times higher odds of having a head/neck melanoma in our case group compared with that in the control group (OR = 2.09, 95% confidence interval = 1.13‒3.86; P = 0.020). Our study is limited by small sample size, and our case cohort lacked diversity regarding race, ethnicity, sex, and geography. Validation of the reported trends could provide more robust guidance for melanoma surveillance in patients with PD.

23 November 2020 in Journal of Nursing Care Quality
Verified
Journal Article
Closed access
BMBenjamin PharmD Mancheril
Benjamin PharmD Mancheril
BKBridgette PharmD Kram
Bridgette PharmD Kram
JSJennifer PharmD Schultheis
Jennifer PharmD Schultheis
SKShawn PharmD Kram
Shawn PharmD Kram
MTMorgan PharmD Trammel
Morgan PharmD Trammel
CCChristopher E. Cox
Christopher E. Cox
Background: Consensus guidelines for pain, agitation, and delirium (PAD) in mechanically ventilated patients recommend maintaining a light level of sedation. Local Problem: Consistent attainment of target PAD assessments in mechanically ventilated ICU patients is often challenging. Methods: This is a single-center, prospective study. Interventions: In the intervention group, a pharmacist provided weekly feedback to nurses on their success in achieving target PAD assessments compared with a historical cohort without feedback. Results: Overall, 478 patients and 205 nurses were included. The odds of having weekly Richmond Agitation-Sedation Scale (RASS) score, pain score goals, and Confusion Assessment Method for the ICU (CAM-ICU) negative assessments at goal between the intervention and control groups fluctuated over time without a discernible trend. Conclusion: The provision of weekly feedback to nurses on PAD nursing assessments by a pharmacist did not impact the achievement of PAD goals among critically ill mechanically ventilated patients.